Ratings by Stifel (Bradley Canino)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/24/2026 | Pyxis Oncology Inc. | PYXS | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2025 | Celcuity Inc | CELC | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (Buy) |
|
Details | ||
| 3/20/2025 | Black Diamond Therapeutics | BDTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2025 | Black Diamond Therapeutics | BDTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2025 | ALX Oncology | ALXO | Maintain | Hold (N/A) |
|
Details | ||
| 3/6/2025 | Merus N.V. | MRUS | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2025 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2025 | Blueprint Medicines | BPMC | Maintain | Buy (Buy) |
|
Details | ||
| 2/18/2025 | ORIC Pharamceuticals | ORIC | Maintain | Buy (Buy) |
|
Details | ||
| 2/12/2025 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 2/12/2025 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2025 | ALX Oncology | ALXO | Maintain | Hold (Hold) |
|
Details | ||
| 1/8/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2024 | ALX Oncology | ALXO | Maintain | Hold (N/A) |
|
Details | ||
| 12/3/2024 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2024 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2024 | Kura Oncology | KURA | Maintain | Hold (N/A) |
|
Details | ||
| 11/15/2024 | Affimed Therapeutics | AFMD | Maintain | Hold (N/A) |
|
Details | ||
| 11/13/2024 | Nuvalent | NUVL | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Kura Oncology | KURA | Maintain | Hold (N/A) |
|
Details | ||
| 11/7/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Black Diamond Therapeutics | BDTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2024 | Blueprint Medicines | BPMC | Maintain | Buy (Buy) |
|
Details | ||
| 10/21/2024 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 10/14/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2024 | Kura Oncology | KURA | Downgrade | Hold (Buy) |
18.24 (10.89) |
-40.3% | Details | |
| 10/7/2024 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Nuvalent | NUVL | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Relay Therapeutics | RLAY | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2024 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2024 | ORIC Pharamceuticals | ORIC | New Coverage | Buy (N/A) |
9.59 (7.54) |
-21.38% | Details | |
| 9/6/2024 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
44.47 (24.81) |
-44.21% | Details | |
| 9/5/2024 | Affimed Therapeutics | AFMD | Maintain | Hold (N/A) |
|
Details | ||
| 8/15/2024 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | ALX Oncology | ALXO | Maintain | Hold (N/A) |
|
Details | ||
| 8/8/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Pyxis Oncology Inc. | PYXS | New Coverage | Buy (N/A) |
3.37 (2.23) |
-33.83% | Details | |
| 8/1/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2024 | Nuvalent | NUVL | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/18/2024 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2024 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2024 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Deciphera | DCPH | Downgrade | Hold (Buy) |
25.37 (25.59) |
0.87% | Details | |
| 5/10/2024 | Nuvalent | NUVL | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2024 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2024 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
27.12 (16.41) |
-39.49% | Details | |
| 4/26/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2024 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2024 | ALX Oncology | ALXO | Maintain | Hold (N/A) |
|
Details | ||
| 4/1/2024 | Affimed Therapeutics | AFMD | Maintain | Hold (N/A) |
|
Details | ||
| 3/8/2024 | ALX Oncology | ALXO | Downgrade | Hold (Buy) |
14.77 (2.07) |
-85.99% | Details | |
| 2/29/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2024 | Celcuity Inc | CELC | New Coverage | Buy (N/A) |
14.40 (88.29) |
513.13% | Details | |
| 2/21/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2024 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2023 | C4 Therapeutics | CCCC | Upgrade | Buy (Hold) |
1.18 (3.58) |
203.39% | Details | |
| 11/14/2023 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | C4 Therapeutics | CCCC | Maintain | Hold (N/A) |
|
Details | ||
| 10/31/2023 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2023 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2023 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2023 | Nuvalent | NUVL | New Coverage | Buy (N/A) |
42.54 (84.66) |
99.01% | Details | |
| 8/10/2023 | Deciphera | DCPH | Upgrade | Buy (Hold) |
12.94 (25.59) |
97.76% | Details | |
| 8/9/2023 | C4 Therapeutics | CCCC | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2023 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2023 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2023 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2023 | Black Diamond Therapeutics | BDTX | Upgrade | Buy (Hold) |
5.73 (3.76) |
-34.38% | Details | |
| 6/12/2023 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2023 | Theseus Pharmaceuticals Inc. | THRX | Maintain | Hold (N/A) |
|
Details | ||
| 5/11/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2023 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | C4 Therapeutics | CCCC | Maintain | Hold (N/A) |
|
Details | ||
| 5/4/2023 | Deciphera | DCPH | Maintain | Hold (N/A) |
|
Details | ||
| 4/20/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2023 | Affimed Therapeutics | AFMD | Maintain | Hold (N/A) |
|
Details | ||
| 3/20/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2023 | Theseus Pharmaceuticals Inc. | THRX | New Coverage | Buy (N/A) |
7.81 (4.06) |
-48.02% | Details | |
| 3/15/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Black Diamond Therapeutics | BDTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/2/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | C4 Therapeutics | CCCC | Maintain | Hold (N/A) |
|
Details | ||
| 12/21/2022 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2022 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Black Diamond Therapeutics | BDTX | Maintain | Hold (N/A) |
|
Details | ||
| 11/4/2022 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | C4 Therapeutics | CCCC | Maintain | Hold (N/A) |
|
Details | ||
| 11/2/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2022 | Affimed Therapeutics | AFMD | Downgrade | Hold (Buy) |
1.90 (0.18) |
-90.53% | Details | |
| 9/27/2022 | Deciphera | DCPH | Maintain | Hold (N/A) |
|
Details | ||
| 9/2/2022 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
22.97 (19.37) |
-15.67% | Details | |
| 8/18/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | C4 Therapeutics | CCCC | Maintain | Hold (N/A) |
|
Details | ||
| 8/4/2022 | Deciphera | DCPH | Maintain | Hold (N/A) |
|
Details | ||
| 8/3/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2022 | Merus N.V. | MRUS | New Coverage | Buy (N/A) |
24.18 (90.00) |
272.21% | Details | |
| 7/29/2022 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2022 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2022 | Turning Point Therapeutics Inc. | TPTX | Maintain | Hold (N/A) |
|
Details | ||
| 5/10/2022 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2022 | Black Diamond Therapeutics | BDTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/4/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Turning Point Therapeutics Inc. | TPTX | Maintain | Hold (N/A) |
|
Details | ||
| 2/28/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | C4 Therapeutics | CCCC | Maintain | Hold (N/A) |
|
Details | ||
| 2/24/2022 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | Blueprint Medicines | BPMC | Upgrade | Buy (Hold) |
68.91 (129.46) |
87.87% | Details | |
| 1/21/2022 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Blueprint Medicines | BPMC | Maintain | Hold (N/A) |
|
Details | ||
| 11/10/2021 | Affimed Therapeutics | AFMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2021 | Deciphera | DCPH | Downgrade | Hold (Buy) |
36.00 (25.59) |
-28.92% | Details | |
| 11/3/2021 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2021 | Blueprint Medicines | BPMC | Maintain | Hold (N/A) |
|
Details | ||
| 10/15/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Hold (N/A) |
|
Details | ||
| 9/30/2021 | ALX Oncology | ALXO | New Coverage | Buy (N/A) |
74.75 (2.07) |
-97.23% | Details | |
| 9/30/2021 | Affimed Therapeutics | AFMD | New Coverage | Buy (N/A) |
6.05 (1.90) |
-68.6% | Details | |
| 9/30/2021 | Zentalis Pharmaceuticals | ZNTL | New Coverage | Buy (N/A) |
61.74 (4.57) |
-92.6% | Details | |
| 9/30/2021 | Black Diamond Therapeutics | BDTX | New Coverage | Hold (N/A) |
9.49 (1.81) |
-80.93% | Details | |
| 9/30/2021 | C4 Therapeutics | CCCC | New Coverage | Hold (N/A) |
49.50 (1.18) |
-97.62% | Details | |
| 9/30/2021 | Turning Point Therapeutics Inc. | TPTX | New Coverage | Hold (N/A) |
69.99 (76.01) |
8.6% | Details | |
| 9/30/2021 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
84.14 (8.03) |
-90.46% | Details | |
| 9/30/2021 | Deciphera | DCPH | New Coverage | Buy (N/A) |
33.25 (36.00) |
8.27% | Details | |
| 9/30/2021 | Kymera Therapeutics | KYMR | New Coverage | Buy (N/A) |
60.82 (30.25) |
-50.26% | Details | |
| 9/30/2021 | Blueprint Medicines | BPMC | New Coverage | Hold (N/A) |
103.81 (68.91) |
-33.62% | Details |
